BTMD Insider Trading

Insider Ownership Percentage: 24.00%
Insider Buying (Last 12 Months): $3,141,551.44
Insider Selling (Last 12 Months): $86,116.32

biote Insider Trading History Chart

This chart shows the insider buying and selling history at biote by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$226kbought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$2M$0$2MTotal Insider BuyingTotal Insider Selling

biote Share Price & Price History

Current Price: $3.51
Price Change: Price Increase of +0.1 (2.93%)
As of 04/22/2025 01:00 PM ET

This chart shows the closing price history over time for BTMD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$3.41Closing price on 04/21/25:

SEC Filings (Institutional Ownership Changes) for biote (NASDAQ:BTMD)

21.68% of biote stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BTMD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$0bought$18ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$5M$0$5MTotal InflowsTotal Outflows
biote logo
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
Read More on biote

Today's Range

Now: $3.51
Low: $3.41
High: $3.50

50 Day Range

MA: $3.90
Low: $3.07
High: $4.92

52 Week Range

Now: $3.51
Low: $3.04
High: $8.44

Volume

14,939 shs

Average Volume

186,120 shs

Market Capitalization

$192.03 million

P/E Ratio

13.44

Dividend Yield

N/A

Beta

1.17

Who are the company insiders with the largest holdings of biote?

biote's top insider shareholders include:
  1. Guines Llc (Major Shareholder)
  2. Stephen Mark Cone (Director)
  3. Mary Elizabeth Conlon (General Counsel)
  4. Robert Charles Peterson (CFO)
Learn More about top insider investors at biote.

Who are the major institutional investors of biote?

biote's top institutional shareholders include:
  1. Sanders Morris Harris LLC — 0.09%
Learn More about top institutional investors of biote stock.

Which institutional investors are selling biote stock?

During the last quarter, BTMD stock was sold by these institutional investors:
  1. Sanders Morris Harris LLC